Our work supports the notion that three overlapping features—low expression of Claudin-3/4/7, high NF-YA long/NF-YA short ratio and a 158-gene signature—mark a specific subset of STAD characterized by mesenchymal features and poor prognosis. This evidence concerns the gene CLDN3 and gastric adenocarcinoma.